Stereotactic body radiation therapy for spinal metastases: A new standard of care

Amanda N. Sacino, Hanbo Chen, Arjun Sahgal, Chetan Bettegowda, Laurence D. Rhines, Pejman Maralani, Kristin J. Redmond

Research output: Contribution to journalReview articlepeer-review

Abstract

Advancements in systemic therapies for patients with metastatic cancer have improved overall survival and, hence, the number of patients living with spinal metastases. As a result, the need for more versatile and personalized treatments for spinal metastases to optimize long-term pain and local control has become increasingly important. Stereotactic body radiation therapy (SBRT) has been developed to meet this need by providing precise and conformal delivery of ablative high-dose-per-fraction radiation in few fractions while minimizing risk of toxicity. Additionally, advances in minimally invasive surgical techniques have also greatly improved care for patients with epidural disease and/or unstable spines, which may then be combined with SBRT for durable local control. In this review, we highlight the indications and controversies of SBRT along with new surgical techniques for the treatment of spinal metastases.

Original languageEnglish (US)
Pages (from-to)S76-S87
JournalNeuro-oncology
Volume26
DOIs
StatePublished - Mar 1 2024

Keywords

  • dose selection
  • local control
  • SBRT
  • spinal metastases
  • target delineation

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Stereotactic body radiation therapy for spinal metastases: A new standard of care'. Together they form a unique fingerprint.

Cite this